NCT03090984View on ClinicalTrials.gov

Evaluation of Contact Phase Activation During Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 8, 2017

Primary Completion Date

July 24, 2017

Study Completion Date

July 24, 2017

Conditions
End Stage Renal Disease
Interventions
DEVICE

PMMA (BKU)

At serial time points before, during and after each study hemodialysis session using a BKU dialyzer, blood samples will be drawn for coagulation activation analyses.

DEVICE

PS (Phylter)

At serial time points before, during and after each study hemodialysis session using a Phylter dialyzer, blood samples will be drawn for coagulation activation

DEVICE

AN69ST (Evodial)

At serial time points before, during and after each study hemodialysis session using an Evodial dialyzer, blood samples will be drawn for coagulation activation

Trial Locations (1)

1090

UZ Brussel, Jette

All Listed Sponsors
lead

Universitair Ziekenhuis Brussel

OTHER

NCT03090984 - Evaluation of Contact Phase Activation During Hemodialysis | Biotech Hunter | Biotech Hunter